SBIR-STTR Award

Antibody probes for human b lymphotropic virus
Award last edited on: 1/30/2014

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$50,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Berge Hampar

Company Information

Bio Molecular Technology Inc (AKA: BMT~BioMolecular Technology Inc)

5340 Spectrum Drive
Frederick, MD 21701
   (301) 831-4068
   bmt1@bmtinc.com
   www.bmtinc.com
Location: Single
Congr. District: 06
County: Frederick

Phase I

Contract Number: N43CP095634-000
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1989
Phase I Amount
$50,000
The human herpes virus type 6 (HHV-6) is a novel herpes virus isolated from fresh human blood mononuclear cells. Although not exclusively associated with acquired immune deficiency syndrome (AIDS), HHV-6 may play a role in lymphoproliferative abnormalities. As a recent virus isolate, little is known of the biological properties of HHV-6, and few reagents are available to investigators in the field. The development of a battery of monoclonal antibody probes of HHV-6 is necessary to facilitate studies aimed at elucidating the role of this virus in humans, including its putative pathological role. In addition to the potential usefulness of such probes to research laboratories, they should prove useful in the development of diagnostic tests employed by clinical laboratories.The Phase I effort will concentrate on developing procedures for generating monoclonal antibodies against HHV-6 structural and nonstructural antigens. The Phase II effort will concentrate on producing a battery of antibodies and developing assay kits for diagnosing HHV-6 infection.

Anticipated Results:
These probes will be used by research laboratories studying the biological activity of HHV-6 and by clinical laboratories in developing diagnostic tests.National Cancer Institute

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----